Damora Therapeutics, Inc.
Damora Therapeutics, Inc. scores highest on Torque (56) and lowest on Price (27). Its PosiPenta is 44.93 out of 100, around the middle of similar companies.
On the Penta Grid this week, Damora Therapeutics, Inc. is Grid #385 of 837 in the Healthcare sector in United States, and Grid #2,421 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Damora Therapeutics, Inc. | 44.93 | 27 | 35 | 55 | 56 | 52 |
| U.S. Physical Therapy, Inc. | 64.09 | 23 | 88 | 91 | 56 | 63 |
| Nektar Therapeutics | 36.68 | 35 | 29 | 27 | 52 | 41 |
| Taysha Gene Therapies, Inc. | 40.74 | 21 | 41 | 37 | 48 | 56 |
| InnovAge Holding Corp. | 61.51 | 13 | 87 | 74 | 56 | 77 |
| Freenome, Inc. | 49.94 | 0 | 24 | 60 | 93 | 72 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -73.76 |
| P/B ratio | 2.21 |
EEarnings
| Trailing EPS | ₹-23.68 |
| Forward EPS | ₹-205.77 |
NNitro
| Price | 1746.54 |
| 52-week high | 3629.95 |
| 52-week low | 468.84 |
| Fall from 52-week high | 51.9% |
TTorque
| Return on equity (ROE) | -99.74% |
| Debt-to-equity | 0.00 |
AAnchor
| Beta (price swings) | 1.44 |
| Market cap | ₹10,782 Cr |
| Insider holding | 8.43% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Damora Therapeutics, Inc.'s PosiPenta score?
Damora Therapeutics, Inc.'s PosiPenta is 44.93 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Damora Therapeutics, Inc. stand on the Penta Grid?
On the Penta Grid this week, Damora Therapeutics, Inc. is Grid #385 of 837 in the Healthcare sector in United States, and Grid #2,421 of 4,000 in United States.
Which PosiPenta pillar is strongest for Damora Therapeutics, Inc.?
Torque (durability), with a score of 56 out of 100: around the middle of similar companies.
Which PosiPenta pillar is weakest for Damora Therapeutics, Inc.?
Price (valuation), with a score of 27 out of 100: weaker than most similar companies.
Has Damora Therapeutics, Inc.'s PosiPenta changed since last week?
Yes, it rose 3.14 points, from 41.79 to 44.93.
PositoAI is for research and education only and is not investment advice.